PMC:7784786 / 1131-1278 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"61","span":{"begin":50,"end":60},"obj":"Species"},{"id":"65","span":{"begin":62,"end":72},"obj":"Chemical"}],"attributes":[{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"Tax:2697049"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"omes from immune system activation in response to SARS-COV-2. Itolizumab is an antibody that recognizes a protein expressed in immune cells. The an"}

{"project":"LitCovid-sentences","denotations":[{"id":"T14","span":{"begin":62,"end":140},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"omes from immune system activation in response to SARS-COV-2. Itolizumab is an antibody that recognizes a protein expressed in immune cells. The an"}